Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01530854 · ClinicalTrials.gov registry record
Plasma Free Fatty Acids in Risk Assessment of Sepsis in the Emergency Department: A Prospective Pilot Study
A clinical trial, sponsored by The Cleveland Clinic.
- Completed
- Registry status
- 74
- Enrollment target
NCT01530854 is a clinical trial that has completed, run by The Cleveland Clinic. The registered enrollment target is 74 participants.
The verdict
NCT01530854 has completed, sponsored by The Cleveland Clinic.
- COMPLETED
- Registry status
- 74 participants
- Enrollment target
Study Summary
Plasma free fatty acids (FFAs) are thought to play a role in the generation of organ dysfunction. The investigators hypothesize that plasma FFA levels are a marker of poor prognosis in patients with sepsis. The present study will examine the relation between plasma FFA levels and severity of illness in patients with sepsis presenting to the Emergency Department. It will also examine the relation between plasma FFA levels and the risk of developing late morbidity, multiple organ dysfunction syndrome (MODS) and/or mortality during initial hospitalization and over a 30-day follow-up period.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 74 participants |
| Start Date | 2008-02 |
| Est. Completion | 2012-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01530854
The ClinicalTrials.gov registry entry for NCT01530854 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 74 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The Cleveland Clinic, which has 688 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01530854 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01530854 about?
NCT01530854 is a clinical study titled "Plasma Free Fatty Acids in Risk Assessment of Sepsis in the Emergency Department: A Prospective Pilot Study". Plasma free fatty acids (FFAs) are thought to play a role in the generation of organ dysfunction. The investigators hypothesize that plasma FFA levels are a marker of poor prognosis in patients with sepsis. The present study will examine the relation between plasma FFA levels and severity of illness...
What is the current status of trial NCT01530854?
This trial is currently completed. The enrollment target is 74 participants. The study started on 2008-02. Estimated completion is 2012-01.
Who is sponsoring clinical trial NCT01530854?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.